Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2013
10/29/2013US8569446 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/29/2013US8569332 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
10/29/2013US8569283 Compounds and compositions as c-Kit kinase inhibitors
10/29/2013US8569248 Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders
10/29/2013US8568799 Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from acacia
10/29/2013US8568748 Pharmaceutical formulation comprising cyclosporin and use thereof
10/29/2013US8568742 Methods and compositions involving immunostimulatory oligodeoxynucleotides
10/29/2013US8568699 Soft anticholinergic zwitterions
10/29/2013CA2678176C Sustained delivery formulations of rapamycin compounds
10/29/2013CA2589204C Recombinant bcg strains with enhanced ability to escape the endosome
10/29/2013CA2546619C Il-23 and its receptor; related reagents and methods
10/29/2013CA2535515C Cd20-binding polypeptide compositions
10/29/2013CA2509136C Human il-1 beta antagonists
10/29/2013CA2458001C Regulation of immune responses by manipulation of intermediary metabolite levels
10/29/2013CA2446408C Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
10/29/2013CA2435672C Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/29/2013CA2396992C Hybrid cells
10/27/2013CA2776119A1 P97 protein and uses thereof as vaccine adjuvant
10/24/2013WO2013159082A1 Compounds and methods for regulating integrins
10/24/2013WO2013158959A1 Compositions and methods for treatment of graft-versus-host disease
10/24/2013WO2013158792A1 Compounds having immunomodulator activity
10/24/2013WO2013158274A1 ANTI-MIGE ANTIBODIES THAT BIND TO THE JUNCTION BETWEEN CH4 AND CεMX DOMAINS
10/24/2013WO2013157961A1 Immunostimulatory compositions and methods of manufacture
10/24/2013WO2013157562A1 Nitrogenated bicyclic aromatic heterocyclic compound
10/24/2013WO2013156608A1 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
10/24/2013WO2013155980A1 Auto-immune disease-related microrna and use thereof
10/24/2013WO2013155865A1 Method for increasing yield of total triterpene compounds in phellinus igniarius
10/24/2013WO2013131947A3 Means for treating allergies and other diseases
10/24/2013US20130281487 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
10/24/2013US20130281470 Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases
10/24/2013US20130280299 Viral vectors and their use in therapeutic methods
10/24/2013US20130280295 Aluminum compounds for use in therapeutics and vaccines
10/23/2013EP2653477A1 Scorpion active peptides and preparation methods and applications thereof
10/23/2013EP2653157A1 Astaxanthin for improving muscle atrophy
10/23/2013EP2651978A1 Use of an antibody directed against a membrane protein
10/23/2013EP2651970A1 Serum amyloid p protein
10/23/2013EP2651937A1 Imidazo [4, 5 -c]quinolin- 1 -yl derivative useful in therapy
10/23/2013EP2651440A1 Cd89 activation in therapy
10/23/2013EP2651435A1 Method for suppressing an immune response
10/23/2013CN103370331A Amino statin derivatives for the treatment of arthrosis
10/23/2013CN103370317A Imidazo [4, 5-c] quinolin-1-yl derivative useful in therapy
10/23/2013CN103369974A Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
10/23/2013CN103360494A Completely anti-CD20 human monoclonal antibody and application thereof
10/23/2013CN103360493A Cross-reactive and bispecific anti-IL 17A/F antibodies
10/23/2013CN103360483A Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity
10/23/2013CN103360276A Crystal form, preparation method and application of agomelatine, as well as medicine composition
10/23/2013CN103357009A Application of Hemokinin-1 in preparation of vaccine adjuvant
10/23/2013CN103356987A Ephedra-containing traditional Chinese medicine and its preparation method
10/23/2013CN103356971A Traditional Chinese medicine composition capable of substantially improving human immunity and preparation method thereof
10/23/2013CN103356956A Traditional Chinese medicine composition for treating autoimmune liver disease and preparation method thereof
10/23/2013CN103356927A Lemon grass dissolved medicine
10/23/2013CN103356890A Externally-applied traditional Chinese medicinal preparation for treating skin allergy and pruritus, and preparation method thereof
10/23/2013CN103356833A Compound preparation used for controlling nutritional diarrhea of weaned piglet
10/23/2013CN103356828A Pharmaceutical composition used for treating eczema
10/23/2013CN103356807A Drug composite with function of enhancing immunity and preparation method thereof
10/23/2013CN103356806A Nutritional wine with body strengthening and beauty maintaining functions
10/23/2013CN103356762A Itching and pain relieving unguent
10/23/2013CN103356756A Traditional Chinese medicine composition for treating allergic rhinitis
10/23/2013CN103356739A Shuanghuanglian oral liquid for livestock and extraction method thereof
10/23/2013CN103356730A Injection for increasing long-distance survival rate and healthy rate of young domestic fowls, and preparation method thereof
10/23/2013CN103356717A Rhizoma Dryopteris Crassirhizomatis extract and its use in preparation of viral disease controlling medicines
10/23/2013CN103356716A Fermented composition of multiple probiotics and composite medicinal and edible fungi, and preparation method and application thereof
10/23/2013CN103356712A Changbai mountain oviductus ranae pure powder particles and preparation method thereof
10/23/2013CN103356711A Immunomodulation using placental stem cells
10/23/2013CN103356710A Treatment of diseases and disorders using placental stem cells
10/23/2013CN103356616A Bilastine-containing pharmaceutical composition and preparation method thereof
10/23/2013CN103356514A Diarylalkanes as potent inhibitors of binuclear enzymes
10/23/2013CN103356481A Ophthalmic emulsions containing immunosuppressive agent
10/23/2013CN103356457A Ginkgo leaf toning lotion
10/23/2013CN103356421A Peel-off pansy mask and preparation method of mask
10/23/2013CN103355843A Endocrine disorders control insole
10/23/2013CN102793766B Preparation method of apostichopus japonicus slow-release type compound immunopotentiator
10/23/2013CN102757880B Maca health-care wine and preparation method thereof
10/23/2013CN102703447B Oligonucleotide with breast cancer treatment effect
10/23/2013CN102464590B Immunomodulator and preparation method thereof as well as application thereof
10/23/2013CN102443063B Anti-TNFalpha humanized Fab, humanized antibody and its application
10/23/2013CN101962402B Astragalus membranaceus glycoprotein as well as preparation method and usage thereof
10/23/2013CN101856347B Extract of leontopodic acid plant and application of active ingredients thereof in treating hepatitis
10/23/2013CN101657443B [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
10/23/2013CN101646690B Antibodies to il-17a
10/23/2013CN101588815B Prostate kallikrein allergen
10/22/2013US8563717 Adenine derivatives
10/22/2013US8563611 Methods and compositions for promoting the respiratory development of an infant
10/22/2013US8563507 Method of treating a disease or condition characterized by aberrant epithelial cell proliferation
10/22/2013US8563007 Immunogenic compositions for the prevention and treatment of meningococcal disease
10/22/2013US8563006 Immunogenic compositions for the prevention and treatment of meningococcal disease
10/22/2013US8563000 Melanocortin receptor ligands modified with hydantoin
10/22/2013US8562968 Use of stem cells and CD6 depleted stem cells for the induction of tolerance to allogenic transplants and/or for the treatment of leukemia
10/22/2013CA2707726C Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
10/22/2013CA2599112C Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
10/22/2013CA2580981C Stabilized human igg4 antibodies
10/22/2013CA2412626C Il-17 molecules and uses thereof
10/17/2013WO2013154878A1 Heterocyclic compounds and uses thereof
10/17/2013WO2013154173A1 Amidopyridine derivative, and use thereof
10/17/2013WO2013153800A1 Method for producing lymphocyte cell group consisting mainly of memory t cells
10/17/2013WO2013153539A1 Tricyclic compounds as tec kinase inhibitors
10/17/2013WO2013153250A1 Glycosaminoglycan-binding of proteins with secret domain encoded by poxvirus
10/17/2013WO2013152717A1 Fused pyrimidine compound, and preparation method, intermediate, composition， and uses thereof
10/17/2013WO2013104995A3 Compositions and methods for treating viral infections
10/17/2013US20130274689 Method for Reducing or Preventing Transplant Rejection in the Eye and Intraocular Implants for Use Therefor
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 1172